Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Possible Influence of Erythropoietin and Early Iron Supplements on the Prevalence and Severity of Retinopathy of Prematurity and Other Short Term Outcome of Prematurity

NCT00339001 is registered in ClinicalTrials.gov with Sheba Medical Center as lead sponsor.

NCT NCT00339001
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00339001 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Possible Influence of Erythropoietin and Early Iron Supplements on the Prevalence and Severity of Retinopathy of Prematurity and Other Short Term Outcome of Prematurity
Lead sponsor
Sheba Medical Center
Phase
Observational
Overall status
Unknown status
Start date
April 30, 2006
Completion date
December 31, 2006
Enrollment
400
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

retinopathy of prematurity